Dr. Aditya Eturi, MD

Dr. Eturi practices at Reading Hospital in West Reading, Pennsylvania, part of Tower Health.

Dr. Eturi's NPI, 1568991297, was assigned on June 6, 2017. Dr. Eturi holds Pennsylvania license MD478749.

Dr. Eturi's primary practice is Reading Hospital, at 420 S 5th Avenue, West Reading, PA 19611 in Berks County. The practice phone is (610) 988-8000.

Dr. Eturi's primary practice is Reading Hospital in West Reading, Pennsylvania, part of Tower Health. Dr. Eturi is also affiliated with Penn State Health St. Joseph Medical Center. The medical group on file is Reading Hospital Cardiology - West Reading. Dmand AI also links Dr. Eturi to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eturi practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Eturi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Eturi's licenses on file in 2 states: Pennsylvania and Rhode Island.

CMS data shows 150 Medicare services from Dr. Eturi across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $12,943 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 97 Medicare patients who saw Dr. Eturi in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eturi's median patient age at 68, with 36% women.

In 2024, Dr. Eturi wrote 139 Medicare Part D claims for 52 patients. 76% of them were for generic drugs. CMS names the drug for 44 of them, across 2 drugs with 11 or more claims each, at $45,896 in total drug cost. In 2020, CMS named 120 claims across 6 drugs.

Dr. Eturi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eturi as offering telehealth.

Dmand AI links 4 papers to Dr. Eturi, published from 2019 to 2024. The most frequent topics are Biomarkers, Tumor and Molecular Targeted Therapy. Dr. Eturi's most frequent co-authors are Kevin Kayvan Zarrabi, MD, Khaldoun Almhanna, MD, MPH and Sami Dwabe.

CMS Open Payments shows 5 general payments to Dr. Eturi from 2 drug and device companies from 2023 to 2024. Speaker and faculty fees make up the largest share, 85% of the total. Exelixis Inc. paid the most, $618.